Skip to main content
. 2017 Jul 4;24(1):1018–1025. doi: 10.1080/10717544.2017.1344335

Figure 5.

Figure 5.

Mean plasma level–time profiles of PLAG after oral administration of S-SNEDDS, commercial soft capsule and drug at a dose equivalent to 200 mg/kg drug in rats. Each value designates the mean ± SD. (n = 8). The S-SNEDDS was composed of PLAG/SLS/HPMC/BHA/calcium silicate at a weight ratio of 1: 0.25: 0.1: 0.0002: 0.5. *p < .05 compared with drug only and commercial soft capsule.